Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 12 January 2026Published: 23 June 2015
Endoscopic bipolar radiofrequency ablation for malignant biliary obstruction (HTG731)Product type:GuidanceProgramme:HealthTech guidancePublished: 14 November 2024
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal) (TA750)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 December 2021
Pancreatic cancer in adults: diagnosis and management (NG85)Product type:GuidanceProgramme:NICE guidelinePublished: 7 February 2018
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer (TA476)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 September 2017
Irreversible electroporation for treating pancreatic cancer (HTG437)Product type:GuidanceProgramme:HealthTech guidancePublished: 3 May 2017
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine (TA440)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 April 2017
Cellvizio confocal endomicroscopy system for characterising pancreatic cysts (MIB69)Product type:AdviceProgramme:Medtech innovation briefingPublished: 28 June 2016
Suspected cancer (QS124)Product type:Quality standardLast updated: 5 December 2017Published: 30 June 2016